Vivani Selling And Marketing Expenses from 2010 to 2024

VANI Stock  USD 1.33  0.04  3.10%   
Vivani Medical's Selling And Marketing Expenses is decreasing with stable movements from year to year. Selling And Marketing Expenses is predicted to flatten to about 305.2 K. For the period between 2010 and 2024, Vivani Medical, Selling And Marketing Expenses quarterly trend regression had mean deviation of  3,505,892 and range of 11 M. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2013-03-31
Previous Quarter
99 K
Current Value
100 K
Quarterly Volatility
929.8 K
 
Yuan Drop
 
Covid
Check Vivani Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vivani Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 388.9 K, Interest Expense of 8.9 M or Selling General Administrative of 7.9 M, as well as many indicators such as Price To Sales Ratio of 28.23, Dividend Yield of 0.0 or PTB Ratio of 2.62. Vivani financial statements analysis is a perfect complement when working with Vivani Medical Valuation or Volatility modules.
  
Check out the analysis of Vivani Medical Correlation against competitors.
For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.

Latest Vivani Medical's Selling And Marketing Expenses Growth Pattern

Below is the plot of the Selling And Marketing Expenses of Vivani Medical over the last few years. It is Vivani Medical's Selling And Marketing Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vivani Medical's overall financial position and show how it may be relating to other accounts over time.
Selling And Marketing Expenses10 Years Trend
Pretty Stable
   Selling And Marketing Expenses   
       Timeline  

Vivani Selling And Marketing Expenses Regression Statistics

Arithmetic Mean4,246,772
Geometric Mean2,169,788
Coefficient Of Variation93.46
Mean Deviation3,505,892
Median2,194,590
Standard Deviation3,969,038
Sample Variance15.8T
Range11M
R-Value(0.27)
Mean Square Error15.7T
R-Squared0.07
Significance0.33
Slope(239,941)
Total Sum of Squares220.5T

Vivani Selling And Marketing Expenses History

2024305.2 K
2023321.3 K
2021357 K
2020701 K
20196.1 M
201811.3 M
20179.6 M

About Vivani Medical Financial Statements

Investors use fundamental indicators, such as Vivani Medical's Selling And Marketing Expenses, to determine how well the company is positioned to perform in the future. Although Vivani Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Selling And Marketing Expenses321.3 K305.2 K

Currently Active Assets on Macroaxis

When determining whether Vivani Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vivani Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vivani Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vivani Medical Stock:
Check out the analysis of Vivani Medical Correlation against competitors.
For more detail on how to invest in Vivani Stock please use our How to Invest in Vivani Medical guide.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vivani Medical. If investors know Vivani will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vivani Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.43)
Return On Assets
(0.29)
Return On Equity
(0.86)
The market value of Vivani Medical is measured differently than its book value, which is the value of Vivani that is recorded on the company's balance sheet. Investors also form their own opinion of Vivani Medical's value that differs from its market value or its book value, called intrinsic value, which is Vivani Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vivani Medical's market value can be influenced by many factors that don't directly affect Vivani Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vivani Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vivani Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vivani Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.